About this item:

100 Views | 35 Downloads

Author Notes:

Yong-Pil Cho, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Asanbyeongwon-gil 86, Songpa-gu, Seoul 05505, Republic of Korea or Young-sup Yoon, Division of Cardiology, Department of Medicine, Emory University School of Medicine, 101 Woodruff Circle, WMB 3309, Atlanta, GA 30322, USA; ypcho@amc.seoul.kr. yyoon5@emory.edu

The authors have no conflict of interests in relation to this article.

Subjects:

Research Funding:

This work was supported in part by grants from NIH (HL127759, DP3DK094346, and DP3DK 108245 to Y-.S.Y.), the Bio & Medical Technology Development Program of the NRF funded by the Korean government (MSIP) (No 2015M3A9C6031514), and the Korea Health Technology R&D Project through the KHIDI, funded by the Ministry of Health & Welfare, Republic of Korea (No HI15C2782).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Surgery
  • Peripheral Vascular Disease
  • Cardiovascular System & Cardiology
  • LYMPHANGIOSARCOMA
  • THERAPY
  • DISEASE

Modified Mouse Models of Chronic Secondary Lymphedema: Tail and Hind Limb Models

Tools:

Journal Title:

ANNALS OF VASCULAR SURGERY

Volume:

Volume 43

Publisher:

, Pages 288-295

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Background Postsurgical secondary lymphedema is usually a progressive and lifelong condition lacking any curative treatment. The aim of this study was to develop new, simple surgical mouse models of chronic lymphedema, better simulating chronic nature of human postsurgical lymphedema. Methods Two experimental mouse models of secondary lymphedema were created surgically without radiation by modifications of the previously described methods: the tail model and the hind limb model. Lymphedema formation was clinically assessed and quantitatively evaluated by measuring circumferences and limb volumes. Postmortem specimens were assessed histologically to examine the efficacy of the models. Results In the tail models, although a substantial frequency of tail necrosis (30.0%) was noted and the increase in circumference was maintained for only limited times postoperatively depending on the particular tail model, the overall success rate was 65.0%. In the mouse hind limb model, the overall success rate was 88.9%, and the increased circumference and limb volume were maintained over the entire study period of 8 weeks. The overall success rate of the mouse hind limb model was significantly higher than that of the mouse tail model(s). Conclusions We have successfully established modified mouse tail and hind limb lymphedema models via only surgical techniques without radiation, which have characteristics of chronic secondary lymphedema. The mouse hind limb model has a higher success rate than the mouse tail model and has advantages of having the healthy contralateral hind limbs as an internal control.

Copyright information:

2017

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/rdf).
Export to EndNote